Dermatology

Emergency Medicine Dermatology

Shannon Toohey, MD, MAEd^*

DOI: https://doi.org/10.21980/J8DW21 Issue 2:2[mrp_rating_result]

By the end of this educational session, the learner will: 1) List the six primary types of rash (maculopapular, petechial/purpura, diffuse erythematous, non-erythematous, vesiculo-bullous, and pustular). 2) Be able to accurately describe various types of lesions and rashes with appropriate terminology; 3) Understand the use of the Modified Lynch Algorithm and how it can be used to narrow down the differential diagnosis in patients presenting with rash.

Dermatology Team Based Learning (TBL)

Infectious Mononucleosis: Pharyngitis and Morbilliform Rash

Eric McCoy, MD, MPH^* and Amal Shafi, BS^*

DOI: https://doi.org/10.21980/J88C7H Issue 2:2[mrp_rating_result]

Her physical exam was significant for bilateral tonsillar exudates, cervical lymphadenopathy, and a morbilliform rash that included the palms (Figure 1-4). Laboratory testing was significant for white blood cell (WBC) count of 16.5 thous/mcl with an elevation in absolute lymphocytes of > 10 thous/mcl. The monospot and EBV (Epstein-Barr virus) panel were positive.

Infectious Disease Dermatology ENT Visual EM

Herpes Zoster

Hamid Ehsani-Nia, BS, MS^* and Robert Rowe, MD^{^}

DOI: https://doi.org/10.21980/J8C301 Issue 2:2[mrp_rating_result]

The patient was in mild distress, afebrile, with stable vital signs. His physical exam revealed an erythematous, grouped vesicular rash in various stages of progression including erythematous papules, clear vesicles, and pustular vesicles. Few lesions were scabbed over. No signs of crusting or scarring were appreciated. The distribution encompassed the entire left T4 dermatome both posteriorly and anteriorly. No other rashes were appreciated elsewhere on the body.

Infectious Disease Dermatology Visual EM

Anaphylaxis Simulation

Christopher Eric McCoy, MD, MPH^*

DOI: https://doi.org/10.21980/J84S3W Issue 2:1[mrp_rating_result]

By the end of this simulation-based session, the learner will be able to: 1) Recognize and diagnose anaphylaxis according to the criteria set forth by the NIAID and FAAN symposium 2) discuss the appropriate dose, concentration, and delivery route of epinephrine for anaphylaxis 3) list and discuss the rationale for the second-line therapeutic options used to treat anaphylaxis, and 4) develop an appropriate disposition algorithm to be used when managing anaphylaxis in the clinical setting.

Dermatology Simulation